Economy

Q2 Sentiment Halozyme Therapeutics Inc (NASDAQ:HALO)

About 1.23M shares traded. It has outperformed by 28.19% the S&P500. A 7 analysts rate it as either a buy or a strong buy, while 1 believe that investors should either steer clear of (NASDAQ:HALO) or, if they already own its stock, sell it. After a recent check, it is observed that the insiders for the firm now own 0.10% shares. Total S A Sponsored Adr now has $133.47 billion valuation. The share price has moved forward from its 20 days moving average, trading at a distance of 18.13% and stays 28.45% away from its 50 days moving average. Prudential Financial Inc (NYSE:PRU) has risen 33.66% since September 30, 2016 and is uptrending. Marinus Pharmaceuticals, Inc. has 0 buy ratings, 0 holds and 0 sells even after the stock climbed 1.91% from its high of $5.96 to a $166.47 million market value through last close. Deutsche Bank has "Buy" rating and $12 target. The stock of Prudential Financial Inc (NYSE:PRU) has "Mkt Perform" rating given on Monday, November 28 by FBR Capital. The stock has "Outperform" rating by Wells Fargo on Friday, December 4. Societe Generale upgraded the shares of TOT in report on Tuesday, September 22 to "Buy" rating. As per Monday, April 18, the company rating was downgraded by Canaccord Genuity. (NASDAQ:HALO). State Board Of Administration Of Florida Retirement Sys reported 91,554 shares stake. The firm has "Overweight" rating given on Thursday, August 4 by Barclays Capital. BlackRock Inc. increased its position in Halozyme Therapeutics by 7,292.8% during the first quarter. The Company operates in research, development and commercialization of human enzymes and other drug candidates. It now has negative earnings. This segment also includes research and development activities and product sales of Hylenex recombinant.

The market capitalization (Stock Price Multiply by Total Number of Outstanding Shares) for the company is reported at $3.92B. Therefore 75% are positive.

Halozyme Therapeutics, Inc.is a biotechnology firm focused on developing and commercializing oncology therapies. Also, the current price highlights a discount of 87.39% to analysts' high consensus price target. ValuEngine raised Halozyme Therapeutics from a "sell" rating to a "hold" rating in a research report on Friday, June 2nd. The rating was maintained by JMP Securities on Tuesday, August 11 with "Market Outperform".

02/01/2016 - Canaccord Genuity began new coverage on Halozyme Therapeutics, Inc. giving the company a "buy" rating. (NASDAQ:HALO) earned "Neutral" rating by Citigroup on Friday, January 6. Barclays Public Ltd Company has invested 0% in Halozyme Therapeutics, Inc. (NASDAQ:HALO) was up +3.98% during the last trading session, with a day high of 17.38. Finally, Piper Jaffray Companies set a $20.00 price target on shares of Halozyme Therapeutics and gave the stock a "buy" rating in a research note on Thursday, August 10th. The company was maintained on Friday, September 15 by BMO Capital Markets.

Investors sentiment increased to 2.02 in Q2 2017. Its up 1.26, from 0.76 in 2017Q1. Bank of New York Mellon Corp increased its position in shares of Halozyme Therapeutics by 27.3% during the first quarter. 119.22 million shares or 5.94% more from 112.53 million shares in 2017Q1 were reported. Synovus Finance Corporation invested in 36,156 shares. Pacad Investment holds 0.12% or 65,887 shares in its portfolio.

08/09/2017 - Halozyme Therapeutics, Inc. had its "underperform" rating reiterated by analysts at Jefferies. (NASDAQ HALO) opened at 17.40 on Friday. Halozyme Therapeutics's revenue was up 1.2% compared to the same quarter previous year. Deutsche Bank initiated Halozyme Therapeutics, Inc. (NASDAQ:MRNS), its shares were trading at $5.87 a gain of $0.58, on the trading floor. Rhumbline Advisers stated it has 134,439 shares or 0% of all its holdings. Sweden-based Rhenman & Prtnrs Asset Ab has invested 0.22% in Halozyme Therapeutics, Inc. (NASDAQ:HALO) for 2.25 million shares. Nationwide Fund Advsrs holds 61,195 shares or 0% of its portfolio.

Halozyme Therapeutics, Inc. has a consensus outperform rating from 10 Wall Street analysts, and the number of shares now sold short amount to at least 16.56% of shares outstanding. See Halozyme Therapeutics, Inc.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.



Like this

Latest


01 October 2017
Analysts See $1.57 EPS for Valero Energy Corporation (VLO)
The stock of Valero Energy Corporation (NYSE:VLO) earned "Outperform" rating by RBC Capital Markets on Wednesday, April 26. Independent Portfolio Consultants Inc. lifted its stake in Valero Energy Corporation by 62.2% in the second quarter.

01 October 2017
Technical Charts and Signs for Discover Financial Services (DFS)
V Wealth Management LLC purchased a new stake in Discover Financial Services during the second quarter valued at about $101,000. Out of 7 Wall Street analysts rating Michael Kors, 0 give it "Buy", 1 "Sell" rating , while 6 recommend "Hold".

01 October 2017
FM Arun Jaitley highlights initiatives of the Income Tax Department
Jaitley observed that there exists further "space and scope" for improvement, especially to reduce "burden on small tax payers". Finance Minister Arun Jaitley who headed the meet spoke of the initiatives of the Income Tax Department past two to three years.

01 October 2017
Brokers Add To Their Ratings On Highwoods Properties, Inc. (NYSE:HIW)
Independent Portfolio Consultants Inc. boosted its holdings in shares of Highwoods Properties by 17.5% during the 2nd quarter. The stock of Highwoods Properties Inc (NYSE:HIW) has "Equal-Weight" rating given on Thursday, May 12 by Morgan Stanley.

01 October 2017
Jose Mourinho Happy to Have Changed Marouane Fellaini Perceptions
Romelu Lukaku has been one of the major differences to Mourinho's side with 11 goals in his first 10 games as a United player. Former Holland coach Danny Blind is a big fan of Manchester United midfielder Henrikh Mkhitaryan .

01 October 2017
SNES Classic Hacking Kicked Off, Free Storage Comparable To NES Classic
There was definitely much more inventory available than for the NES Classic launch, but the new Nintendo console still sold out. Watch the cool SNES Classic Teardown video by Jerry Rig Everything at the end of this report to see it for yourself.

01 October 2017
Next Weeks Broker Price Targets For H&E Equipment Services, Inc. (NASDAQ:HEES)
BidaskClub upgraded H&E Equipment Services from a "buy" rating to a "strong-buy" rating in a report on Tuesday, August 1st. Traders are a little more bullish on H&E Equipment Services, Inc. of late if you take note of the fall in short interest.

01 October 2017
(CSGP) Shares now up at $268.25 CoStar Group, Inc. Announces Exercise of…
BidaskClub downgraded CoStar Group from a "strong-buy" rating to a "buy" rating in a research report on Sunday, July 16th. Zacks Investment Research lowered CoStar Group from a "buy" rating to a "hold" rating in a report on Tuesday, June 6th.

01 October 2017
EPS for UnitedHealth Group Inc (UNH) Expected At $2.57
Facebook enables people to connect, share, discover and communicate with each other on mobile devices and personal computers. The healthcare conglomerate reported $2.46 EPS for the quarter, topping the consensus estimate of $2.38 by $0.08.

01 October 2017
FedEx Corporation (FDX) Rating Reiterated by Bank of America Corporation
Profund Advsrs Lc stated it has 6,004 shares. 55,370 are held by Chesley Taft Assoc Ltd Liability Corporation. (NASDAQ:MU). With 3.08M avg volume, 3 days are for Pepsico Incorporated (NYSE:PEP)'s short sellers to cover PEP's short positions.



Recommended